1Ali H, A1-SarrafM. Chemotherapy in advanced nasopharyngeal cancer. Ontology (Williston Park ) , 2000, 14 ( 8 ) :1223.
2Hoffman H , Cooper J S , Weber R , et al. Changing patterns of practice in the management of nasopharynx carcinoma (NPC) : Analysisof the National Cancer Database ( NCDB ). J Clin Oncol ,2004 ,22:5501.
3Al-Sarraf M , LeBlanc M , Shanker Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. Phase III randomized Intergroup study 0099 . J Clin Oncol ,1998 ,16 (4) :1310 - 1317.
4Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclo-phosphamide, and doxorubicin after radiotherapy inlocalregional nasopharyngeal cancer:results of a 42year multicenter randomized study. J Clin Oncol, 1988,6 ( 9 ) : 1401 - 1410.
5Li Zhang, Chong Zhao, Pei Jian Peng, et al. Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma : Preliminary results. J Clin Oncol,2005 33:8461 - 8468.
6Lee A W M , Lau W H , Tung S Y, et al. Preliminary result s of a randomized study on therapeutic gain by concurrent chemothera py for regionally advanced nasopharyn-geal carcinoma : NPC- 9901 trial by t he Hong Kong Nasopharyngeal Cancer Study- Group. J Clin Oncol ,2005 ,28:6966- 6975.
7Lin J C , J an J S , Hsu C Y, et al. Phase III study of concurrent chemoradiot herapy versus radiot herapy alone for advanced nasopharyngeal carcinoma : positive effect on overall and progression free survival . J Clin Oncol ,2003 ,21 (4) :631 - 637.
8Chart A T , Ngan R , Teo P , et al . Overall survival after concurrent cisplatin2radiot herapy compared wit h radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. Journal of the National Cancer Institute , 2005 , 97 (7) :536 - 539.
9Lee N , Xia P , Quivey JM, et al. Intensity2modulated radiotherapy in the treatment of nasopharyngeal carcinoma : an update of the UCSF experience. Int J Radiat Oneol Biol Phys ,2002 ,53 (1) :12-22.
